Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells.

Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells. Abstract Text:

    naoki ishiguroNaoki Ishiguro,masanobu oyabuMasanobu Oyabu,toshihiro satoToshihiro Sato,tomoji maedaTomoji Maeda,hironobu minamiHironobu Minami,ikumi tamaiIkumi Tamai,naoki ishiguroNaoki Ishiguro,masanobu oyabuMasanobu Oyabu,toshihiro satoToshihiro Sato,tomoji maedaTomoji Maeda,hironobu minamiHironobu Minami,ikumi tamaiIkumi Tamai,

    PURPOSE: We investigated whether gefitinib, an anticancer agent, inhibits phosphatidylcholine (PC) biosynthesis and choline uptake by alveolar epithelial type II cells. MATERIALS AND METHODS: Uptake of choline and PC biosynthesis were examined in vitro, using human alveolar epithelia-derived cell line A549 and rat alveolar type (AT) II cells as models. RESULTS: Gefitinib reduced the incorporation of [(3)H]choline into PC in A549 and rat ATII cells. The uptake of [(3)H]choline by A549 and rat ATII cells was concentration-dependent, and the Km values were 15.0 and 10-100 muM, respectively. The uptake of [(3)H]choline by A549 and rat ATII cells was weakly Na(+)-dependent, and inhibited by hemicholinium-3. RT-PCR revealed expression of choline transporter-like protein (CTL)1 and organic cation transporter (OCT)3 mRNAs in both cells. The choline uptake by A549 and rat ATII cells was strongly inhibited by gefitinib with the IC(50) value of 6.77 muM and 10.5 muM, respectively. CONCLUSIONS: Our results demonstrate that gefitinib reduces PC biosynthesis via inhibition of cellular choline uptake by A549 and rat ATII cells, which is mainly mediated by CTL1, resulting in abnormality of lung surfactant that can be one of mechanisms of the interstitial lung disease associated with gefitinib.

    Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells. Publishing Authors By Initials

    n ishiguroN Ishiguro,m oyabuM Oyabu,t satoT Sato,t maedaT Maeda,h minamiH Minami,i tamaiI Tamai,n ishiguroN Ishiguro,m oyabuM Oyabu,t satoT Sato,t maedaT Maeda,h minamiH Minami,i tamaiI Tamai,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Pharmaceutical research

    VOLUME: 25

    Page Numbers: 417-27

    Journal Abbreviation: Pharm. Res.

    ISSN: 0724-8741

    DAY: 12

    MONTH: 07

    YEAR: 2007

    Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8406521

    Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells.

    AFFILIATION: Department of Membrane Transport and Pharmacokinetics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamasaki, Noda, Chiba, 278-8510, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Pharm Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News